Efficacy and tolerability of tolterodine in children with detrusor hyperreflexia
- 1 March 2000
- Vol. 55 (3) , 414-418
- https://doi.org/10.1016/s0090-4295(99)00477-x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- ONCE DAILY CONTROLLED VERSUS IMMEDIATE RELEASE OXYBUTYNIN CHLORIDE FOR URGE URINARY INCONTINENCEJournal of Urology, 1999
- Tolterodine in the treatment of overactive bladder: analysis of the pooled phase II efficacy and safety dataUrology, 1999
- Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladderBritish Journal of Urology, 1998
- Urodynamic Effects of Oral Oxybutynin Chloride in Children With Myelomeningocele and Detrusor HyperreflexiaUrology, 1998
- Tolterodine – a new bladder-selective antimuscarinic agentEuropean Journal of Pharmacology, 1997
- Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: urodynamic evaluationWorld Journal of Urology, 1997
- Complications of Intravesical Oxybutynin Chloride Therapy in the Pediatric Myelomeningocele PopulationJournal of Urology, 1997
- Urodynamic and other effects of tolterodine: A novel antimuscarinic drug for the treatment of detrusor overactivityNeurourology and Urodynamics, 1995
- Toward a new classification of overactive bladdersNeurourology and Urodynamics, 1995
- Oxybutinin and the Prevention of Urinary Incontinence in Spina bifidaEuropean Urology, 1985